Obesity Pharmacotherapy Outline
{"Image DocumentName": "Obesity Pharmacotherapy Outline", "Image ImageDescription": "How to apply drug trial data to clinical practice. Principles of obesity medication use in clinical practice. Medications approved for long-term use. sibutramine (Meridia) orlistat (Xenical) Medications approved for short term use. phentermine. others rarely used: mazindol, diethylpropion. Medications for use in special patients. the depressed obese patient \u2013 bupropion (Wellbutrin) and venlafaxine (Effexor) type 2 diabetes \u2013 metformin , pramlintide (Symlin), exendin-4 (Exenatide) patients with neuropsychiatric problems - topiramate (Topamax) and zonisamide (Zonegran) Medications in development.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}